Clinical Trials Browser

Interventional × Hematologic Neoplasms × magrolimab × Clear all

NCT03248479 2025-01-17

Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies

Phase 1 Terminated

258 enrolled 38 charts

Other hematologic neoplasm

Hematologic Neoplasms